Dose-response analysis of aripiprazole in patients with schizophrenia in Taiwan
Background: Aripiprazole is a third-generation antipsychotic agent with acceptable efficacy and a good safety profile. Previous studies have indicated the therapeutic serum concentration of aripiprazole to be 100 to 350 ng/ml; however, most of these studies examined a Western population. Patients wi...
Saved in:
Main Authors: | Yun Tien (Author), Hsiang-Ping Huang (Author), Ding-Lieh Liao (Author), Shang-Chien Huang (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2022-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Schizophrenia: effects of aripiprazole in metabolic syndrome
by: Deborah Galvão Coelho da Silva, et al.
Published: (2019) -
Switching to Aripiprazole as a Strategy for Weight Reduction: A Meta-Analysis in Patients Suffering from Schizophrenia
by: Yoram Barak, et al.
Published: (2011) -
Hypoprolactinemia and hyperprolactinemia in male schizophrenia patients treated with aripiprazole and risperidone and their relationships with testosterone levels
by: Minami Tasaki, et al.
Published: (2021) -
Aripiprazole LAI two‐injection start in a 16 year‐old adolescent with schizophrenia
by: Virginio Salvi, et al.
Published: (2022) -
Long-acting injectable aripiprazole in pregnant women with schizophrenia: a case-series report
by: Blanca Fernández-Abascal, et al.
Published: (2021)